FIRM FIXED PRICE

ABBOTT RAPID DX NORTH AMERICA LLC - BINAXNOW COVID-19 TESTS

PIID: 36C25924F0067

Signed Date: Oct 17, 2025Effective Date: Dec 15, 2023End Date: Closed on Dec 14, 2024

Award $

$86K

Vendor

ABBOTT RAPID DX NORTH AMERICA LLC

NAICS

325413

Signed Date

Oct 17, 2025

Key Details

Dollars Obligated

$85,844.88

Base & All Options

$-81,236.16

Awarding Agency

Department of Veterans Affairs

Awarding Sub-Agency

Department of Veterans Affairs

NAICS Code

325413 - IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Product Service Code

6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

AURORA, CO, 800457603, CD-CO-06

Description

BINAXNOW COVID-19 TESTS

Context & Analysis

On Oct 17, 2025, Department of Veterans Affairs obligated $85,844.88 to ABBOTT RAPID DX NORTH AMERICA LLC for binaxnow covid-19 tests. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in AURORA, CO. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325413 — related awards are listed below.